Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods of treating NSCLC comprising administering platinum doublet chemotherapy followed by an anti-PD-1 antibody and an anti-CTLA-4 antibody

US Patent 12479917 · Granted Nov 25, 2025

Assignee

Inventors

View full patent text on Google Patents →